Biogen Inc. buy Guggenheim
Start price
21.07.26
/
50%
€176.66
Target price
21.07.27
€245.39
Performance (%)
2.33%
Price
04.08.26
€180.78
Summary
This prediction is currently active. The BUY prediction by Guggenheim shows slight gains of 2.33%. This prediction currently runs until 21.07.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Biogen Inc. | -0.144% |
| iShares Core DAX® | 3.258% |
| iShares Nasdaq 100 | 5.697% |
| iShares Nikkei 225® | 7.770% |
| iShares S&P 500 | 2.795% |
Comments by Guggenheim for this prediction
In the thread Biogen Inc. diskutieren
Biogen (BIIB) had its "buy" rating reaffirmed by Guggenheim. They now have a $280.00 price target on the stock, up from $260.00.
Ratings data for BIIB provided by MarketBeat